You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Treatment of the following infections when caused by susceptible strains of the designated microorganisms. Respiratory tract infections. Caused by S. pneumoniae and group A beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present). Bacterial sinusitis. Caused by streptococci, S. pneumoniae and S. aureus (methicillin sensitive only). Otitis media. Due to S. pneumoniae, staphylococci. Skin and skin structure infections. Caused by staphylococci and/or streptococci. Genitourinary tract infections, including acute prostatitis. Caused by E. coli, P. mirabilis, and klebsiella sp. The effectiveness of cephalexin in the treatment of bacterial infections of the brain and spinal column has not been established and cephalexin is not indicated in these conditions. Note: appropriate culture and susceptibility tests should be initiated prior to and during therapy to determine susceptibility of the causative organism to cephalexin. Renal function studies should be performed when indicated.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Treatment of the following infections when caused by susceptible strains of the designated microorganisms. Respiratory tract infections. Caused by S. pneumoniae and group A beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present). Bacterial sinusitis. Caused by streptococci, S. pneumoniae and S. aureus (methicillin sensitive only). Otitis media. Due to S. pneumoniae, staphylococci. Skin and skin structure infections. Caused by staphylococci and/or streptococci. Genitourinary tract infections, including acute prostatitis. Caused by E. coli, P. mirabilis, and klebsiella sp. The effectiveness of cephalexin in the treatment of bacterial infections of the brain and spinal column has not been established and cephalexin is not indicated in these conditions. Note: appropriate culture and susceptibility tests should be initiated prior to and during therapy to determine susceptibility of the causative organism to cephalexin. Renal function studies should be performed when indicated.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Treatment of the following infections when caused by susceptible strains of the designated microorganisms. Respiratory tract infections. Caused by S. pneumoniae and group A beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present). Bacterial sinusitis. Caused by streptococci, S. pneumoniae and S. aureus (methicillin sensitive only). Otitis media. Due to S. pneumoniae, staphylococci. Skin and skin structure infections. Caused by staphylococci and/or streptococci. Genitourinary tract infections, including acute prostatitis. Caused by E. coli, P. mirabilis, and klebsiella sp. The effectiveness of cephalexin in the treatment of bacterial infections of the brain and spinal column has not been established and cephalexin is not indicated in these conditions. Note: appropriate culture and susceptibility tests should be initiated prior to and during therapy to determine susceptibility of the causative organism to cephalexin. Renal function studies should be performed when indicated.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Treatment of the following infections when caused by susceptible strains of the designated microorganisms. Respiratory tract infections. Caused by S. pneumoniae and group A beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present). Bacterial sinusitis. Caused by streptococci, S. pneumoniae and S. aureus (methicillin sensitive only). Otitis media. Due to S. pneumoniae, staphylococci. Skin and skin structure infections. Caused by staphylococci and/or streptococci. Genitourinary tract infections, including acute prostatitis. Caused by E. coli, P. mirabilis, and klebsiella sp. The effectiveness of cephalexin in the treatment of bacterial infections of the brain and spinal column has not been established and cephalexin is not indicated in these conditions. Note: appropriate culture and susceptibility tests should be initiated prior to and during therapy to determine susceptibility of the causative organism to cephalexin. Renal function studies should be performed when indicated.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Treatment of the following infections when caused by susceptible strains of the designated microorganisms. Respiratory tract infections. Caused by S. pneumoniae and group A beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present). Bacterial sinusitis. Caused by streptococci, S. pneumoniae and S. aureus (methicillin sensitive only). Otitis media. Due to S. pneumoniae, staphylococci. Skin and skin structure infections. Caused by staphylococci and/or streptococci. Genitourinary tract infections, including acute prostatitis. Caused by E. coli, P. mirabilis, and klebsiella sp. The effectiveness of cephalexin in the treatment of bacterial infections of the brain and spinal column has not been established and cephalexin is not indicated in these conditions. Note: appropriate culture and susceptibility tests should be initiated prior to and during therapy to determine susceptibility of the causative organism to cephalexin. Renal function studies should be performed when indicated.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Treatment of the following infections when caused by susceptible strains of the designated microorganisms. Respiratory tract infections. Caused by S. pneumoniae and group A beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present). Bacterial sinusitis. Caused by streptococci, S. pneumoniae and S. aureus (methicillin sensitive only). Otitis media. Due to S. pneumoniae, staphylococci. Skin and skin structure infections. Caused by staphylococci and/or streptococci. Genitourinary tract infections, including acute prostatitis. Caused by E. coli, P. mirabilis, and klebsiella sp. The effectiveness of cephalexin in the treatment of bacterial infections of the brain and spinal column has not been established and cephalexin is not indicated in these conditions. Note: appropriate culture and susceptibility tests should be initiated prior to and during therapy to determine susceptibility of the causative organism to cephalexin. Renal function studies should be performed when indicated.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Treatment of the following infections when caused by susceptible strains of the designated microorganisms. Respiratory tract infections. Caused by S. pneumoniae and group A beta-haemolytic streptococci (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present). Bacterial sinusitis. Caused by streptococci, S. pneumoniae and S. aureus (methicillin sensitive only). Otitis media. Due to S. pneumoniae, staphylococci. Skin and skin structure infections. Caused by staphylococci and/or streptococci. Genitourinary tract infections, including acute prostatitis. Caused by E. coli, P. mirabilis, and klebsiella sp. The effectiveness of cephalexin in the treatment of bacterial infections of the brain and spinal column has not been established and cephalexin is not indicated in these conditions. Note: appropriate culture and susceptibility tests should be initiated prior to and during therapy to determine susceptibility of the causative organism to cephalexin. Renal function studies should be performed when indicated.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.